Gut Microbiome and Blood Markers After Habitual Herbal Tea Consumption
NCT ID: NCT05862532
Last Updated: 2023-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
55 participants
INTERVENTIONAL
2022-11-17
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
TeTrimTeas have created herbal green tea blends, improving on existing Chinese formulation, and would like to test it as 'health tea'. The recruited cohort will be randomised into one of three intervention teas (green tea control, senna herbal mix and rhubarb root herbal mix). They would like to explore if consumption of the teas for 21 days has an impact on digestion and potentially help control weight gain.
Aberystwyth University will use high resolution metabolomics to investigate the chemical composition of capillary blood samples, in particular the short chain fatty acids. They will also assess lipid composition in capillary bloods and the microbiome of stools. Diet data, stool consistency and anthropometric measurements will be collected pre and post intervention. Results will advance product development and data would be used in grant applications into the health benefits of the herbal teas.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Green Tea Extract and Ginger
NCT07150533
The Effects of Jing-Si Herbal Tea Liquid Packets and Jing-Si Herbal Tang Heng Power Drink
NCT06522412
The Safety and Intake Rate of a Natural Compound Arctigenin in Healthy Men
NCT03703388
Herbal Tonic Fertile Supplement(ZO2C5)
NCT01895816
Investigate Beneficial Effect of Herbal Tea in Jordanian Adults
NCT04093128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The experimental sequence
'Diet-monitoring' period (two days before the study)
Prior to the experimental session it is important that all participants undergo a period where foods are recorded. This will help the researchers interpret any results after consumption of the test/control food. The researchers would ask them to refrain from taking any over-the-counter medication (such as ibuprofen, paracetamol, aspirin, cough/ cold remedies) or herbal supplements, and to let us know if they find that it is necessary to take any such medication during the trial.
Experimental session- 21 days
Morning: Participants will come to WARU or Trimsaran Community Health Centre for their pre-organised timeslot to allow researchers to collect a fasted capillary (fingerpick) blood samples and stool sample. They may consume their breakfast after their visit. They will also collect their tea bags. Researchers will also take participants weight and height and collect diet data (PDQS) and stool scores (Bristol Stool scale).
Over 21 days: the researchers would ask the participants to consume a cup of tea after their last meal/snack of the day (post 6pm) daily, for 21 days. The researchers would ask them not to consume anything after the tea. In a cup/mug the researchers would ask them to place a 2.5g tea bag and add 190ml of hot water (80-100◦C) and stir clockwise 10 consecutive times to allow for optimal infusion and then allow to brew for 5 minutes, before removal.
After the experimental period:
Before their final visit (or at their final visit): the researchers would like participants to fill in another food questionnaire and a stool scale.
Morning of their final visit. The researchers would ask the participant to come to WARU or Trimsaran Community Health Centre for their pre-organised timeslot to allow us to collect a fasted capillary (fingerpick) blood samples and stool sample. The researchers will also take their weight and height. They may consume their breakfast after their visit. Afterwards, they can go back to their 'normal' eating pattern.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Welsh Herbal tea with Senna
Welsh Herbal tea with green tea and Senna
TeTrimTeas welsh Herbal tea with senna
TeTrimTeas welsh Herbal tea with green tea and senna
Welsh Herbal tea with rhubarb root
Welsh Herbal tea with green tea and rhubarb root
TeTrimTeas welsh Herbal tea with rhubarb root
TeTrimTeas welsh Herbal tea with green tea and rhubarb root
Green tea
Dartmoor green tea
TeTrimTeas welsh Herbal tea with green tea
TeTrimTeas welsh Herbal tea with green tea
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TeTrimTeas welsh Herbal tea with rhubarb root
TeTrimTeas welsh Herbal tea with green tea and rhubarb root
TeTrimTeas welsh Herbal tea with senna
TeTrimTeas welsh Herbal tea with green tea and senna
TeTrimTeas welsh Herbal tea with green tea
TeTrimTeas welsh Herbal tea with green tea
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Commit to fasting capillary blood collection
* Commit to stool sampling collection
* Able to refrain from taking any over-the-counter medication or herbal supplements during the diet monitoring and experimental periods.
* Able to prepare and consume the tea during the experimental days, after the last meal/snack of the day and not to consume anything afterwards
* Fill in diet diaries, FFQ and stool ranking
* Able to inform the researcher if any antibiotics or heavy alcohol is consumed over the intervention period
Exclusion Criteria
* Higher risk or vulnerable from coronavirus or live with someone at a higher risk of a severe illness from COVID-19 (over 70, undergoing cancer treatment, high risk of getting infections).
* Had a letter from the NHS advising you to shield (isolate)
* Had been at risk of exposure to COVID-19 such as travel, contact with someone with COVID-19, been exposed to the virus, or has been asked to self-isolate by the track and trace system.
* Serious health conditions that require daily long-term medications (including immunosuppressants)
* A history or current diabetes, lung issues, gut inflammation (Crohns, IBD), digestive disorders
* Diagnosed with a serious health condition within the last 12 months
* Pregnant
* Play sports at a high level (more than 7h/week or 1h/day)
* Smoking
* consume high dose of alcohol \> 21 unit per week for men and \> 14 units per week for women
* Food allergy /food intolerance/ eating disorder or are on a specially prescribed diet
* If the potential participant has had COVID-19 previously (and are fully recovered and not within isolation) then they are eligible to join the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TeTrimTeas Cyf
UNKNOWN
Aberystwyth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Well-being and Health Assessment Research Unit (WARU)
Aberystwyth, Ceredigion, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23306
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.